Liming Lin
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Health and Disease Prevention
Papers in
-
- Cardiac Fibrosis and Remodeling 6
- Blood Pressure and Hypertension Studies 4
- Heart Failure Treatment and Management 4
- Renin-Angiotensin System Studies 4
-
- Vitamin D Research Studies 4
- Co-authors
- Chao Tsang Lu (6 shared papers)Guilan Quan (6 shared papers)Chuanbin Wu (6 shared papers)Rui Luo (5 shared papers)Yuwei Zheng (4 shared papers)Dongyi Xian (4 shared papers)Jinxiu Lin (7 shared papers)Xin Pan (4 shared papers)
- Journals
- International Immunopharmacology (3 papers)Acta Biomaterialia (2 papers)ESC Heart Failure (2 papers)International Journal of Molecular Medicine (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Liming Lin
61 papers receiving 970 citations
Peers
Comparison fields: 5 of 87
- Microbiology 85
- Cardiology and Cardiovascular Medicine 170
- Rehabilitation 44
- Pharmaceutical Science 38
- Nephrology 36
Countries citing papers authored by Liming Lin
This map shows the geographic impact of Liming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Lin more than expected).
Fields of papers citing papers by Liming Lin
This network shows the impact of papers produced by Liming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Lin. The network helps show where Liming Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 149 | |
| 2 | 2022 | 114 | |
| 3 | 2015 | 50 | |
| 4 | 2023 | 41 | |
| 5 | 2016 | 37 | |
| 6 | 2019 | 34 | |
| 7 | 2021 | 32 | |
| 8 | 2024 | 32 | |
| 9 | 2021 | 30 | |
| 10 | 2015 | 29 | |
| 11 | 2018 | 29 | |
| 12 | 2010 | 24 | |
| 13 | 2016 | 23 | |
| 14 | 2017 | 20 | |
| 15 | 2010 | 18 | |
| 16 | 2022 | 18 | |
| 17 | 2024 | 18 | |
| 18 | 2021 | 17 | |
| 19 | 2013 | 16 | |
| 20 | 2024 | 16 |
About Liming Lin
Liming Lin is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Plant Science, Microbiology and Immunology, having authored 66 papers that have together received 986 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (6 papers), Ubiquitin and proteasome pathways (5 papers), Plant Virus Research Studies (5 papers), Blood Pressure and Hypertension Studies (4 papers), Heart Failure Treatment and Management (4 papers), Vitamin D Research Studies (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Renin-Angiotensin System Studies (4 papers). The work is most often cited by research in Microbiology (85 citations), Cardiology and Cardiovascular Medicine (170 citations), Rehabilitation (44 citations), Pharmaceutical Science (38 citations) and Nephrology (36 citations). Liming Lin has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Chao Tsang Lu, Guilan Quan, Chuanbin Wu, Rui Luo, Yuwei Zheng, Dongyi Xian, Jinxiu Lin, Xin Pan, Meifang Wu and Xiaoqian Feng. Their work appears in journals such as International Immunopharmacology, Acta Biomaterialia, ESC Heart Failure, International Journal of Molecular Medicine and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.